Br Med J (Clin Res Ed)  1985;291:97-104 (13 July), doi:10.1136/bmj.291.6488.97

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

The main aim of the trial was to determine whether drug treatment of mild hypertension (phase V diastolic pressure 90-109 mm Hg) reduced the rates of stroke, of death due to hypertension, and of coronary events in men and women aged 35-64 years. Subsidiary aims were: to compare the course of blood pressure in two groups, one taking bendrofluazide and one taking propranolol, and to compare the incidence of suspected adverse reactions to these two drugs. The study was single blind and based almost entirely in general practices; 17 354 patients were recruited, and 85 572 patient years of observation have accrued. Patients were randomly allocated at entry to take bendrofluazide or propranolol or placebo tablets. The primary results were as follows. The stroke rate was reduced on active treatment: 60 strokes occurred in the treated group and 109 in the placebo group, giving rates of 1.4 and 2.6 per 1000 patient years of observation respectively (p less than 0.01 on sequential analysis). Treatment made no difference, however, to the overall rates of coronary events: 222 events occurred on active treatment and 234 in the placebo group (5.2 and 5.5 per 1000 patient years respectively). The incidence of all cardiovascular events was reduced on active treatment: 286 events occurred in the treated group and 352 in the placebo group, giving rates of 6.7 and 8.2 per 1000 patient years respectively (p less than 0.05 on sequential analysis). For mortality from all causes treatment made no difference to the rates. There were 248 deaths in the treated group and 253 in the placebo group (rates 5.8 and 5.9 per 1000 patient years respectively). Several post hoc analyses of subgroup results were also performed but they require very cautious interpretation. The all cause mortality was reduced in men on active treatment (157 deaths versus 181 in the placebo group; 7.1 and 8.2 per 1000 patient years respectively) but increased in women on active treatment (91 deaths versus 72; 4.4 and 3.5 per 1000 patient years respectively). The difference between the sexes in their response to treatment was significant (p = 0.05). Comparison of the two active drugs showed that the reduction in stroke rate on bendrofluazide was greater than that on propranolol (p = 0.002). The stroke rate was reduced in both smokers and non-smokers taking bendrofluazide but only in non-smokers taking propranolol. This difference between the responses to the two drugs was significant (p = 0.03).(ABSTRACT TRUNCATED AT 400 WORDS)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Fagard, R. H. (2009). Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes. Diabetes Care 32: S429-S431 [Full text]  
• CHE, Q., SCHREIBER, M. J. JR, RAFEY, M. A. (2009). Beta-blockers for hypertension: Are they going out of style?. Cleveland Clinic Journal of Medicine 76: 533-542 [Abstract] [Full text]  
• Thomson, R. (2009). Evidence based implementation of complex interventions. BMJ 339: b3124-b3124 [Full text]  
• Paton, J. F. R., Dickinson, C. J., Mitchell, G. (2009). Harvey Cushing and the regulation of blood pressure in giraffe, rat and man: introducing 'Cushing's mechanism'. Exp Physiol 94: 11-17 [Abstract] [Full text]  
• Fan, X., Han, Y., Sun, K., Wang, Y., Xin, Y., Bai, Y., Li, W., Yang, T., Song, X., Wang, H., Fu, C., Chen, J., Shi, Y., Zhou, X., Wu, H., Hui, R. (2008). Sex Differences in Blood Pressure Response to Antihypertensive Therapy in Chinese Patients with Hypertension. The Annals of Pharmacotherapy 42: 1772-1781 [Abstract] [Full text]  
• Dawes, M. G., Bartlett, G., Coats, A. J., Juszczak, E. (2008). Comparing the Effects of White Coat Hypertension and Sustained Hypertension on Mortality in a UK Primary Care Setting. Ann Fam Med 6: 390-396 [Abstract] [Full text]  
• Rothwell, P M (2008). Prognostic models. PN 8: 242-253 [Abstract] [Full text]  
• Cutler, J. A., Davis, B. R. (2008). Thiazide-Type Diuretics and {beta}-Adrenergic Blockers as First-Line Drug Treatments for Hypertension. Circulation 117: 2691-2705 [Full text]  
• Seda, O., Tremblay, J., Gaudet, D., Brunelle, P.-L., Gurau, A., Merlo, E., Pilote, L., Orlov, S. N., Boulva, F., Petrovich, M., Kotchen, T. A., Cowley, A. W. Jr, Hamet, P. (2008). Systematic, Genome-Wide, Sex-Specific Linkage of Cardiovascular Traits in French Canadians. Hypertension 51: 1156-1162 [Abstract] [Full text]  
• Fagard, R. H., Staessen, J. A., Thijs, L., Celis, H., Bulpitt, C. J., de Leeuw, P. W., Leonetti, G., Tuomilehto, J., Yodfat, Y. (2007). On-Treatment Diastolic Blood Pressure and Prognosis in Systolic Hypertension. Arch Intern Med 167: 1884-1891 [Abstract] [Full text]  
• Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full text]  
• McCormack, J. P. (2007). Les betabloquants ont-ils un role dans le traitement de l'hypertension?: NON. cfp 53: 618-621 [Full text]  
• Cooper, C. J., Murphy, T. P. (2007). The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis. Circulation 115: 263-270 [Full text]  
• Sever, P., Dahlof, B., Poulter, N., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S., Kristinsson, A., McInnes, G., Mehlsen, J., Nieminem, M., O'Brien, E., Ostergren, J., on behalf of the ASCOT Steering Committee Members, (2006). Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J 27: 2982-2988 [Abstract] [Full text]  
• Fairhead, J. F, Rothwell, P. M (2006). Underinvestigation and undertreatment of carotid disease in elderly patients with transient ischaemic attack and stroke: comparative population based study. BMJ 333: 525-527 [Abstract] [Full text]  
• Zhang, H., Thijs, L., Staessen, J. A. (2006). Blood Pressure Lowering for Primary and Secondary Prevention of Stroke. Hypertension 48: 187-195 [Full text]  
• Sever, P. S., Poulter, N. R., Elliott, W. J., Jonsson, M. C., Black, H. R., Sever, P. S., Poulter, N. R., Elliott, W. J., Jonsson, M. C., Black, H. R. (2006). Blood Pressure Reduction Is Not the Only Determinant of Outcome. Circulation 113: 2754-2774 [Full text]  
• Khan, N., McAlister, F. A. (2006). Re-examining the efficacy of {beta}-blockers for the treatment of hypertension: a meta-analysis. CMAJ 174: 1737-1742 [Abstract] [Full text]  
• Zillich, A. J., Haines, S. T. (2006). ASHP Therapeutic Position Statement on the Treatment of Hypertension.. Am J Health Syst Pharm 63: 1074-1080 [Full text]  
• Psaty, B. M., Weiss, N. S., Furberg, C. D. (2006). Recent Trials in Hypertension: Compelling Science or Commercial Speech?. JAMA 295: 1704-1706 [Full text]  
• Mancia, G., Grassi, G. (2005). Efficacy of antihypertensive treatment: which endpoints should be considered?. Nephrol Dial Transplant 20: 2301-2303 [Full text]  
• Eddy, D. M., Schlessinger, L., Kahn, R. (2005). Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes. ANN INTERN MED 143: 251-264 [Abstract] [Full text]  
• Wang, J.-G., Staessen, J. A., Franklin, S. S., Fagard, R., Gueyffier, F. (2005). Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome. Hypertension 45: 907-913 [Abstract] [Full text]  
• Okin, P. M., Devereux, R. B., Jern, S., Kjeldsen, S. E., Julius, S., Nieminen, M. S., Snapinn, S., Harris, K. E., Aurup, P., Edelman, J. M., Wedel, H., Lindholm, L. H., Dahlof, B., for the LIFE Study Investigators, (2004). Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events. JAMA 292: 2343-2349 [Abstract] [Full text]  
• Devereux, R. B., Wachtell, K., Gerdts, E., Boman, K., Nieminen, M. S., Papademetriou, V., Rokkedal, J., Harris, K., Aurup, P., Dahlof, B. (2004). Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension. JAMA 292: 2350-2356 [Abstract] [Full text]  
• Messerli, F. H., Fournier, A. (2004). Reply. J Am Coll Cardiol 44: 2097-2098 [Full text]  
• Sever, P. (2004). The VALUE trial: a commentary. Journal of Renin-Angiotensin-Aldosterone System 5: 99-101 [Abstract]  
• Task Force Members, , Lopez-Sendo, J., Swedberg, K., McMurray, J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Pedersen, C. T., ESC Committee for Practice Guidelines, , Priori, S. G., Alonso Garcia, M. A., Blanc, J.-J., Budaj, A., Cowie, M., Dean, V., Deckers, J., Fernandez Burgos, E., Lekakis, J., Lindahl, B., Mazzotta, G., McGregor, K., Morais, J., Oto, A., Smiseth, O. A., Document Reviewers, , Alonso Garcia, M. A., Ardissino, D., Avendano, C., Lundqvist, C. B., ment, D. C., Drexler, H., Ferrari, R., Fox, K. A., Julian, D., Kearney, P., Klein, W., ber, L. K., Mancia, G., Nieminen, M., Ruzyllo, W., Simoons, M., Thygesen, K., Tognoni, G., Tritto, I., Wallentin, L. (2004). Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology. Eur Heart J 25: 1341-1362 [Full text]  
• Davis, B. R., Furberg, C. D., Wright, J. T. Jr., Cutler, J. A., Whelton, P., the ALLHAT Collaborative Research Group, (2004). ALLHAT: Setting the Record Straight. ANN INTERN MED 141: 39-46 [Abstract] [Full text]  
• Fournier, A., Messerli, F. H., Achard, J. M., Fernandez, L. (2004). Cerebroprotection mediated by angiotensin II: A hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol 43: 1343-1347 [Abstract] [Full text]  
• Lawes, C. M.M., Bennett, D. A., Feigin, V. L., Rodgers, A. (2004). Blood Pressure and Stroke: An Overview of Published Reviews. Stroke 35: 1024-1033 [Abstract] [Full text]  
• Lawes, C. M.M., Bennett, D. A., Feigin, V. L., Rodgers, A. (2004). Blood Pressure and Stroke: An Overview of Published Reviews. Stroke 35: 776-785 [Abstract] [Full text]  
• Benediktsson, R., Padfield, P.L. (2004). Maximizing the benefit of treatment in mild hypertension:three simple steps to improve diagnostic accuracy. QJM 97: 15-20 [Abstract] [Full text]  
• Sartori, M., Semplicini, A., Siffert, W., Mormino, P., Mazzer, A., Pegoraro, F., Mos, L., Winnicki, M., Palatini, P. (2003). G-Protein {beta}3-Subunit Gene 825T Allele and Hypertension: A Longitudinal Study in Young Grade I Hypertensives. Hypertension 42: 909-914 [Abstract] [Full text]  
• Mcinnes, G. T (2003). `Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT): The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). British Journal of Diabetes & Vascular Disease 3: 263-267 [Abstract]  
• Petrie, J. R, Kirby, M. (2003). Commonly asked questions: hypertension. British Journal of Diabetes & Vascular Disease 3: 270-273  
• Psaty, B. M., Lumley, T., Furberg, C. D., Schellenbaum, G., Pahor, M., Alderman, M. H., Weiss, N. S. (2003). Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents: A Network Meta-analysis. JAMA 289: 2534-2544 [Abstract] [Full text]  
• Staessen, J. A, Wang, J.-G., Birkenhager, W. H (2003). Outcome beyond blood pressure control?. Eur Heart J 24: 504-514 [Full text]  
• Terao, T., Messerli, F. H., Grossman, E., Ko, D. T., Hebert, P. R., Curtis, J. P., Krumholz, H. M., Sedrakyan, A., Coffey, C. S. (2002). {beta}-Blocker Therapy and Depression. JAMA 288: 1845-1846 [Full text]  
• Sharp, A., Mayet, J. (2002). Regression of left ventricular hypertrophy: hoping for a longer life. Journal of Renin-Angiotensin-Aldosterone System 3: 141-144 [Abstract]  
• Ko, D. T., Hebert, P. R., Coffey, C. S., Sedrakyan, A., Curtis, J. P., Krumholz, H. M. (2002). {beta}-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction. JAMA 288: 351-357 [Abstract] [Full text]  
• Boutitie, F., Gueyffier, F., Pocock, S., Fagard, R., Boissel, J. P., for the INDANA Project Steering Committee, (2002). J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data. ANN INTERN MED 136: 438-448 [Abstract] [Full text]  
• Bulpitt, C. J (2001). Review: The management of the elderly with hypertension. Journal of Renin-Angiotensin-Aldosterone System 2: 11-13  
• Sever, P. S (2000). To block the renin system or the calcium channel in hypertension -- where do we stand?. Journal of Renin-Angiotensin-Aldosterone System 1: 325-327  
• Diercks, G.F.H, van Boven, A.J, Hillege, H.L, Janssen, W.M.T, Kors, J.A, de Jong, P.E, Grobbee, D.E, Crijns, H.J.G.M, van Gilst, W.H (2000). Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 21: 1922-1927 [Abstract]  
• Hollenberg, N. K, Sever, P. S (2000). The past, present and future of hypertension management: a potential role for AT1-receptor antagonists. Journal of Renin-Angiotensin-Aldosterone System 1: 5-10 [Abstract]  
• Cruickshank, J.M (2000). Beta-blockers continue to surprise us. Eur Heart J 21: 354-364  
• Wolk, R. (2000). Arrhythmogenic mechanisms in left ventricular hypertrophy. Europace 2: 216-223 [Abstract]  
• Frohlich, E. D. (1999). The necessity for recognition and treatment of patients with "mild" hypertension. J Am Coll Cardiol 34: 1369-1377 [Abstract] [Full text]  
• Kendall, M. J., Cohen, J. D., Messerli, F. H., Grossman, E., Goldbourt, U. (1999). {beta}-Blockers as First-Line Agents for Hypertension in the Elderly. JAMA 281: 131-133 [Full text]  
• Messerli, F. H., Grossman, E., Goldbourt, U. (1998). Are {beta}-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review. JAMA 279: 1903-1907 [Abstract] [Full text]  
• Kostis, J. B., Davis, B. R., Cutler, J., Grimm, R. H. Jr, Berge, K. G., Cohen, J. D., Lacy, C. R., Perry, H. M. Jr, Blaufox, M. D., Wassertheil-Smoller, S., Black, H. R,, Schron, E., Berkson, D. M., Curb, J. D., Smith, W. M., McDonald, R., Applegate, W. B. (1997). Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension. JAMA 278: 212-216 [Abstract]  
• Michalewiz, L., Chambers, R., Grodzicki, T. (1997). Primary Prevention of Cardiovascular Disease Endpoints Using {beta}-Blockers. JAMA 277: 1759-1759 [Abstract]  
• Psaty, B. M., Smith, N. L., Koepsell, T. D., Furberg, C. D. (1997). Primary Prevention of Cardiovascular Disease Endpoints Using {beta}-Blockers-Reply. JAMA 277: 1759-1760 [Abstract]  
• Psaty, B. M., Smith, N. L., Siscovick, D. S., Koepsell, T. D., Weiss, N. S., Heckbert, S. R., Lemaitre, R. N., Wagner, E. H., Furberg, C. D. (1997). Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis. JAMA 277: 739-745 [Abstract]  
• Ramsay, L. E. (1997). The Hypertension Detection and Follow-up Program: 17 Years On. JAMA 277: 167-170 [Abstract]  
• DeQuattro, V., Li, D. (1997). Antihypertensive Therapy in Patients Undergoing Noncardiac Surgery. J CARDIOVASC PHARMACOL THER 2: 331-335 [Abstract]  
• Gleerup, G., Petersen, J. R., Mehlsen, J., Winther, K. (1996). Effect of Spirapril and Hydrochlorothiazide on Platelet Function and Euglobulin Clot Lysis Time in Patients with Mild Hypertension. ANGIOLOGY 47: 951-956 [Abstract]  
• Goldstein, S. (1996). {beta}-Blockers in Hypertensive and Coronary Heart Disease. Arch Intern Med 156: 1267-1276 [Abstract]  
• Lewis, C. E., Grandits, G. A., Flack, J., McDonald, R., Elmer, P. J. (1996). Efficacy and Tolerance of Antihypertensive Treatment in Men and Women With Stage 1 Diastolic Hypertension: Results of the Treatment of Mild Hypertension Study. Arch Intern Med 156: 377-385 [Abstract]  
• Manolio, T. A., Cutler, J. A., Furberg, C. D., Psaty, B. M., Whelton, P. K., Applegate, W. B. (1995). Trends in Pharmacologic Management of Hypertension in the United States. Arch Intern Med 155: 829-837 [Abstract]  
• Mulrow, C. D., Cornell, J. A., Herrera, C. R., Kadri, A., Farnett, L., Aguilar, C. (1994). Hypertension in the Elderly: Implications and Generalizability of Randomized Trials. JAMA 272: 1932-1938 [Abstract]  
• (1994). Can the Cost of Care Be Contained and Quality of Care Maintained in the Management of Hypertension?. Arch Intern Med 154: 1665-1672 [Abstract]  
• Johannesson, M. (1994). The Impact of Age on the Cost - Effectiveness of Hypertension Treatment: An Analysis of Randomized Drug Trials. Med Decis Making 14: 236-244 [Abstract]  
• Prisant, L. M., Carr, A. A., Bottini, P. B., Solursh, D. S., Solursh, L. P. (1994). Sexual Dysfunction With Antihypertensive Drugs. Arch Intern Med 154: 730-736 [Abstract]  
• Murphy, D. J., Povar, G. J., Pawlson, L. G. (1994). Setting Limits in Clinical Medicine. Arch Intern Med 154: 505-512 [Abstract]  
• Kuhn, F. E., Rackley, C. E. (1993). Coronary Artery Disease in Women: Risk Factors, Evaluation, Treatment, and Prevention. Arch Intern Med 153: 2626-2636 [Abstract]  
• Burris, J. F. (1993). {beta}-Blockers, Dyslipidemia, and Coronary Artery Disease: A Reassessment. Arch Intern Med 153: 2085-2092 [Abstract]  
• Neaton, J. D., Grimm, R. H. Jr, Prineas, R. J., Stamler, J., Grandits, G. A., Elmer, P. J., Cutler, J. A., Flack, J. M., Schoenberger, J. A., McDonald, R., Lewis, C. E., Liebson, P. R., the Treatment of Mild Hypertension Study Research, , Lewis, C. E., Raines, J., Joffrion, I., Allen, R. E., Jones, L., Parker, D., De Worth, J. K., Anzelone, E., Gunn, D., George, A., Montgomery, J., Schoenberger, J. A., Liebson, P. R., Neri, G. S., Betz, E., Mascitti, B., Plank, E., Peterson, B., Remijas, T., Washington, W., Turner, I., Stefanie, L., Aye, P., Madnek-Oxman, S., Jones, H., Flack, J. M., Mascioli, S. R., Van Heel, N., Bjerk, C., Galle, F., Laqua, P., Miller, M., Bell, L. M., Robinson, M. E., Thorson, C., McDonald, R., Townsend, R., Caggiula, A., Dianzumba, S., Ciak, C., Link, M., Hall, B., Monske, M., Theobald, T. M., Berry, M., Coyne, T., Bunker, C. A., Kramer, K., Neaton, J. D., Grandits, G. A., DuChene, A. G., Holland, L. A., Tze, S., Sjolund, S., Launer, C. A., Lagus, J., Miller, C. M., Svendsen, K. H., Leon, A., Grimm, R. H. Jr, Elmer, P. J., Laing, B., McDonald, M., Surbey, D., Wiche, M. K., Kuiper, K., Remington, R., Coates, T. J., Devereux, R., Gifford, R. W. Jr, Langford, H., McCullough, L., Tyroler, H. A. (1993). Treatment of Mild Hypertension Study: Final Results. JAMA 270: 713-724 [Abstract]  
• Weetman, D.F. (1993). The Modelling Paradox: How to Reach the Majority?. Indoor and Built Environment 2: 61-63  
• Pope, J. E., Anderson, J. J., Felson, D. T. (1993). A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure. Arch Intern Med 153: 477-484 [Abstract]  
• Psaty, B. M., Furberg, C. D., Kuller, L. H., Borhani, N. O., Rautaharju, P. M., O'Leary, D. H., Bild, D. E., Robbins, J., Fried, L. P., Reid, C. (1992). Isolated Systolic Hypertension and Subclinical Cardiovascular Disease in the Elderly: Initial Findings From the Cardiovascular Health Study. JAMA 268: 1287-1291 [Abstract]  
• Alderman, M. H. (1992). Which Antihypertensive Drugs First-- and Why!. JAMA 267: 2786-2787 [Abstract]  
• Phillips, S. J., Whisnant, J. P. (1992). Hypertension and the Brain. Arch Intern Med 152: 938-945 [Abstract]  
• The Trials of Hypertension Prevention Collaborativ, , Members of the Trials of Hypertension Prevention C, , Clinical Centers, , Whelton, P. K., Appel, L., Charleston, J., Dalcin, A. T., Ewart, C., Fried, L., Kaidy, D., Klag, M. J., Kumanyika, S., Steffen, L., Walker, W. G., Oberman, A., Counts, K., Hataway, H., Raczynski, J., Rappaport, N., Weinsier, R., Borhani, N. O., Bernauer, E., Borhani, P., de la Cruz, C., Ertl, A., Heustis, D., Lee, M., Lovelace, W., O'Connor, E., Peel, L., Sugars, C., Taylor, J. O., Corkery, B. W., Evans, D. A., Keough, M. E., Morris, M. C., Pistorino, E., Sacks, F., Cameron, M., Corrigan, S., Wright, N. K., Applegate, W. B., Brewer, A., Goodwin, L., Miller, S., Murphy, J., Randle, J., Sullivan, J., Lasser, N. L., Batey, D. M., Dolan, L., Hamill, S., Kennedy, P., Lasser, V. I., Kuller, L. H., Caggiula, A. W., Milas, N. C., Yamamoto, M. E., Vogt, T. M., Greenlick, M. R., Hollis, J., Stevens, V., Cohen, J. D., Mattfeldt-Beman, M., Brinkmann, C., Roth, K., Shepek, L., Coordinating Center, , Hennekens, C. H., Buring, J., Cook, N., Danielson, E., Eberlein, K., Gordon, D., Hebert, P., MacFadyen, J., Mayrent, S., Rosner, B., Satterfield, S., Tosteson, H., Van Denburgh, M., Project Office, , Cutler, J. A., Brittain, E., Farrand, M., Kaufmann, P., Lakatos, E., Obarzanek, E., Central Laboratory, , Belcher, J., Dommeyer, A., Mills, I., Neibling, P., Nutrient Data Center, , Woods, M., Goldman, B.J. K., Blethen, E., Sacks, F. (1992). The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I. JAMA 267: 1213-1220 [Abstract]  
• McCloskey, L. W., Psaty, B. M., Koepsell, T. D., Aagaard, G. N. (1992). Level of Blood Pressure and Risk of Myocardial Infarction Among Treated Hypertensive Patients. Arch Intern Med 152: 513-520 [Abstract]  
• Chang, S. W., Fine, R., Siegel, D., Chesney, M., Black, D., Hulley, S. B. (1991). The Impact of Diuretic Therapy on Reported Sexual Function. Arch Intern Med 151: 2402-2408 [Abstract]  
• Applegate, W. B., Phillips, H. L., Schnaper, H., Shepherd, A. M. M., Schocken, D., Luhr, J. C., Koch, G. G., Park, G. D. (1991). A Randomized Controlled Trial of the Effects of Three Antihypertensive Agents on Blood Pressure Control and Quality of Life in Older Women. Arch Intern Med 151: 1817-1823 [Abstract]  
• Moser, M., Hebert, P., Hennekens, C. H. (1991). An Overview of the Meta-analyses of the Hypertension Treatment Trials. Arch Intern Med 151: 1277-1279 [Abstract]  
• Warram, J. H., Laffel, L. M. B., Valsania, P., Christlieb, A. R., Krolewski, A. S. (1991). Excess Mortality Associated With Diuretic Therapy in Diabetes Mellitus. Arch Intern Med 151: 1350-1356 [Abstract]  
• The Treatment of Mild Hypertension Research Group, (1991). The Treatment of Mild Hypertension Study: A Randomized, Placebo-Controlled Trial of a Nutritional-Hygienic Regimen Along With Various Drug Monotherapies. Arch Intern Med 151: 1413-1423 [Abstract]  
• SHEP Cooperative Research Group, (1991). Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255-3264 [Abstract]  
• Schmieder, R. E., Rockstroh, J. K., Messerli, F. H. (1991). Antihypertensive Therapy: To Stop or Not to Stop?. JAMA 265: 1566-1571 [Abstract]  
• Bostick, R. M., Luepker, R. V., Kofron, P. M., Pirie, P. L. (1991). Changes in Physician Practice for the Prevention of Cardiovascular Disease. Arch Intern Med 151: 478-484 [Abstract]  
• Cummings, D. M., Amadio, P. Jr, Nelson, L., Fitzgerald, J. M. (1991). The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension. Arch Intern Med 151: 250-259 [Abstract]  
• Working Group on Management of Patients with Hyper, (1991). National Education Programs Working Group Report on the Management of Patients with Hypertension and High Blood Cholesterol. ANN INTERN MED 114: 224-237 [Abstract]  
• Moser, M., Blaufox, M. D., Freis, E., Gifford, R. W. Jr, Kirkendall, W., Langford, H., Shapiro, A., Sheps, S. (1991). Who Really Determines Your Patients' Prescriptions?. JAMA 265: 498-500 [Abstract]  
• Edelson, J. T., Weinstein, M. C., Tosteson, A. N. A., Williams, L., Lee, T. H., Goldman, L. (1990). Long-term Cost-effectiveness of Various Initial Monotherapies for Mild to Moderate Hypertension. JAMA 263: 407-413 [Abstract]  
• Olsson, G., Tuomilehto, J., Wikstrand, J. (1989). MAPHY and the Two Arms of HAPPHY-Reply. JAMA 262: 3272-3273 [Abstract]  
• FREIS, E. D. (1989). Critique of the Clinical Importance of Diurectic-Induced Hypokalemia and Elevated Cholesterol Level. Arch Intern Med 149: 2640-2648 [Abstract]  
• MOSER, M., SHEPS, S. (1989). Confusing Messages From the Newest of the {beta}-Blocker/Diuretic Hypertension Trials: The Metoprolol Atherosclerosis Prevention in Hypertensives Trial. Arch Intern Med 149: 2174-2175 [Abstract]  
• Alderman, M. H., Ooi, W. L., Madhavan, S., Cohen, H. (1989). Treatment-Induced Blood Pressure Reduction and the Risk of Myocardial Infarction. JAMA 262: 920-924 [Abstract]  
• Applegate, W. B. (1989). Hypertension in Elderly Patients. ANN INTERN MED 110: 901-915 [Abstract]  
• Psaty, B. M., Koepsell, T. D., LoGerfo, J. P., Wagner, E. H., Inui, T. S. (1989). {beta}-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure. JAMA 261: 2087-2094 [Abstract]  
• Materson, B. J., Reda, D., Freis, E. D., Henderson, W. G., the Veterans Administration Cooperative Study Grou, , Freis, E. D., Materson, B. J., Talmers, F. N., Cushman, W. C., Schnaper, H., White, T. J., Hla, K. M., Fernandez, O., Ramirez, E. A., Khatri, I., Gregory, B., Metcalfe, M., Pawelak, J., Derrington, P., Reece, S., Grossman, K., Smith, M., Haran, E., Natal, M., Quinn, D., Ming, B., Lindle, S. B., Reda, D., Flamenbaum, W., Hamburger, R., Young, L., McMahon, F. G., Gifford, R. Jr, Hawkins, C. M., Oster, J. R., Lamdin, E., Ochi, S., Thomas, J. R., McKoy, J., Moran, P., Davidson, M., Elmer, K., Hagans, J. A., Huang, P., James, K., Henderson, W. G., Sather, M., Freis, E. D., Thomas, J. R., Talmers, F. N., Cushman, W. C., Schnaper, H., White, T. J., Fernandez, O., Ramirez, E. A., Khatri, I., Gregory, B., Metcalfe, M., Grant, C., Pawelak, J., Derrington, P., McKnight, A., Reece, S., Grossman, K., Smith, M., Haran, E., Natal, M., Hackett, W., Quinn, D., Tosch, T. J., Ivie, J., Vitek, M. E., Foregger, J., Young, L., Kirkendall, W., Gunnels, J. C., Hawkins, C. M., Materson, B. J., Alexander, J. C., Meyer, J., Caloza, D. L. Jr, McKoy, J., Moran, P., Davidson, M., Elmer, K., Hagans, J. A., Huang, P., Henderson, W. G., Ivie, J., Vitek, M. E., Sather, M. (1988). Cigarette Smoking Interferes With Treatment of Hypertension. Arch Intern Med 148: 2116-2119 [Abstract]  

Online poll

Find out more on doc2doc >>